Exploring structure–activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme

Terminal deoxynucleotidyl transferase (TdT) is overexpressed in some cancer types, where it drives the mutagenic repair of double strand breaks through non canonical non-homologous end joining pathway. The TdT enzyme belongs to the X family of polymerases, together with the DNA polymerase λ (pol λ) and β (pol β). However, TdT exclusively displays template-independent nucleotide polymerisation. Pursuing our studies in developing TdT inhibitors, herein we deepened the structure-activity relationships of new structural analogues of our previously identified hit compounds. The diketo hexenoic acid derivatives here analysed showed high selectivity towards TdT and inhibition potencies spanning from the low micromolar range to the nanomolar. Docking studies highlighted the chemical features involved in the TdT binding, well contributing to the rationalisation of the structural requirements needed for the enzymatic inhibition.

Authors

Institutions

Publication Details

Journal
Journal of Enzyme Inhibition and Medicinal Chemistry
Published
2025-06-09
DOI
https://doi.org/10.1080/14756366.2025.2496782
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring structure–activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme

Emmanuele Crespan, Giuseppe Ruggieri, Antonella Messore, Elisa Mentegari et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
HIV/AIDS drug development and treatment
article

Exploring structure–activity relationships of pyrrolyl diketo acid derivatives as non-nucleoside inhibitors of terminal deoxynucleotidyl transferase enzyme

Emmanuele Crespan, Giuseppe Ruggieri, Antonella Messore, Elisa Mentegari, Marco Artico, Davide Ialongo, Luigi Scipione, Valentina Noemi Madia, Roberta Costi, Roberto Di Santo, Elisa Patacchini, Nadia Garibaldi, Antonio Coluccia, Francesco Saccoliti, Valeria Tudino, Giovanni Maga, Laura Zarbo, Emanuele Cara
article en

Abstract

Terminal deoxynucleotidyl transferase (TdT) is overexpressed in some cancer types, where it drives the mutagenic repair of double strand breaks through non canonical non-homologous end joining pathway. The TdT enzyme belongs to the X family of polymerases, together with the DNA polymerase λ (pol λ) and β (pol β). However, TdT exclusively displays template-independent nucleotide polymerisation. Pursuing our studies in developing TdT inhibitors, herein we deepened the structure-activity relationships of new structural analogues of our previously identified hit compounds. The diketo hexenoic acid derivatives here analysed showed high selectivity towards TdT and inhibition potencies spanning from the low micromolar range to the nanomolar. Docking studies highlighted the chemical features involved in the TdT binding, well contributing to the rationalisation of the structural requirements needed for the enzymatic inhibition.

Journal of Enzyme Inhibition and Medicinal ChemistryVol. 40(1)
University of Siena (IT), University of Pavia (IT), Istituto di Genetica Molecolare (IT), Institute of Molecular Genetics (RU), Istituto Pasteur (IT), Link Campus University (IT), The Sense Innovation and Research Center (CH), Sapienza University of Rome (IT)
Openalex Percentile: Top 83%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.